Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Ofev
(NINTEDANIB)Orphan drugstandardBoehringer Ingelheim Pharmaceuticals, Inc.
12.1 Mechanism of Action Nintedanib is a small molecule that inhibits multiple receptor tyrosine kinases (RTKs) and non-receptor tyrosine kinases (nRT...
Browse all Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome news →
View all Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome specialists →